This white paper examines the efficacy of RFA at reducing nodule size, with post-treatment evaluations ranging from 6 months to 10 years.
RFA has been shown to reduce the size of thyroid nodules durably in multiple clinical studies.
Park et al.5 studied the efficacy of RFA of benign nodules with 421 patients. Average nodule size was reduced by:
Jeong et al.6 evaluated RFA treatment of low-risk papillary microcarcinoma in 65 patients. The average nodule volume reduction reported was: